Subbu Nambi
Stock Analyst at Guggenheim
(3.46)
# 911
Out of 5,156 analysts
73
Total ratings
42.86%
Success rate
8.02%
Average return
Main Sectors:
Stocks Rated by Subbu Nambi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BLLN BillionToOne | Reiterates: Buy | $120 | $72.11 | +66.41% | 1 | Mar 5, 2026 | |
| NAUT Nautilus Biotechnology | Maintains: Buy | $2.5 → $4 | $2.51 | +59.36% | 2 | Feb 27, 2026 | |
| WAT Waters | Reiterates: Buy | $440 | $305.67 | +43.95% | 1 | Feb 10, 2026 | |
| TWST Twist Bioscience | Maintains: Buy | $77 → $79 | $48.33 | +63.46% | 3 | Jan 26, 2026 | |
| SOPH SOPHiA GENETICS | Maintains: Buy | $6 → $7 | $4.49 | +55.90% | 2 | Jan 26, 2026 | |
| PSNL Personalis | Maintains: Buy | $12 → $13 | $8.16 | +59.31% | 2 | Jan 26, 2026 | |
| ILMN Illumina | Maintains: Buy | $144 → $170 | $124.28 | +36.79% | 5 | Jan 26, 2026 | |
| GRAL GRAIL | Maintains: Buy | $100 → $130 | $49.82 | +160.94% | 3 | Jan 26, 2026 | |
| GH Guardant Health | Maintains: Buy | $115 → $135 | $91.20 | +48.03% | 8 | Jan 26, 2026 | |
| CSTL Castle Biosciences | Maintains: Buy | $43 → $47 | $27.02 | +73.95% | 3 | Jan 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $53 → $58 | $37.20 | +55.91% | 5 | Jan 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $21 | $14.95 | +40.47% | 2 | Jan 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $12 | $9.70 | +23.71% | 4 | Jan 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $50 | $33.37 | +49.84% | 5 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $230 → $270 | $205.22 | +31.57% | 3 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $250 → $275 | $198.80 | +38.33% | 3 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $103.71 | - | 4 | Nov 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $115 → $170 | $94.51 | +79.88% | 2 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $92.11 | - | 1 | Oct 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $95 | $52.32 | +81.57% | 4 | Sep 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $36 | $19.00 | +89.47% | 2 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $8.09 | +23.61% | 1 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.81 | - | 2 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $20.91 | - | 3 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $127.89 | - | 1 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $1.39 | - | 1 | Dec 14, 2023 |
BillionToOne
Mar 5, 2026
Reiterates: Buy
Price Target: $120
Current: $72.11
Upside: +66.41%
Nautilus Biotechnology
Feb 27, 2026
Maintains: Buy
Price Target: $2.5 → $4
Current: $2.51
Upside: +59.36%
Waters
Feb 10, 2026
Reiterates: Buy
Price Target: $440
Current: $305.67
Upside: +43.95%
Twist Bioscience
Jan 26, 2026
Maintains: Buy
Price Target: $77 → $79
Current: $48.33
Upside: +63.46%
SOPHiA GENETICS
Jan 26, 2026
Maintains: Buy
Price Target: $6 → $7
Current: $4.49
Upside: +55.90%
Personalis
Jan 26, 2026
Maintains: Buy
Price Target: $12 → $13
Current: $8.16
Upside: +59.31%
Illumina
Jan 26, 2026
Maintains: Buy
Price Target: $144 → $170
Current: $124.28
Upside: +36.79%
GRAIL
Jan 26, 2026
Maintains: Buy
Price Target: $100 → $130
Current: $49.82
Upside: +160.94%
Guardant Health
Jan 26, 2026
Maintains: Buy
Price Target: $115 → $135
Current: $91.20
Upside: +48.03%
Castle Biosciences
Jan 26, 2026
Maintains: Buy
Price Target: $43 → $47
Current: $27.02
Upside: +73.95%
Jan 26, 2026
Maintains: Buy
Price Target: $53 → $58
Current: $37.20
Upside: +55.91%
Jan 26, 2026
Maintains: Buy
Price Target: $20 → $21
Current: $14.95
Upside: +40.47%
Jan 9, 2026
Maintains: Buy
Price Target: $8 → $12
Current: $9.70
Upside: +23.71%
Jan 5, 2026
Maintains: Buy
Price Target: $45 → $50
Current: $33.37
Upside: +49.84%
Jan 5, 2026
Maintains: Buy
Price Target: $230 → $270
Current: $205.22
Upside: +31.57%
Jan 5, 2026
Maintains: Buy
Price Target: $250 → $275
Current: $198.80
Upside: +38.33%
Nov 21, 2025
Downgrades: Neutral
Price Target: n/a
Current: $103.71
Upside: -
Oct 29, 2025
Maintains: Buy
Price Target: $115 → $170
Current: $94.51
Upside: +79.88%
Oct 16, 2025
Initiates: Neutral
Price Target: n/a
Current: $92.11
Upside: -
Sep 26, 2025
Maintains: Buy
Price Target: $80 → $95
Current: $52.32
Upside: +81.57%
Aug 13, 2025
Maintains: Buy
Price Target: $32 → $36
Current: $19.00
Upside: +89.47%
Apr 16, 2025
Reiterates: Buy
Price Target: $10
Current: $8.09
Upside: +23.61%
Apr 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $4.81
Upside: -
Jun 26, 2024
Downgrades: Neutral
Price Target: n/a
Current: $20.91
Upside: -
Jun 18, 2024
Initiates: Neutral
Price Target: n/a
Current: $127.89
Upside: -
Dec 14, 2023
Initiates: Neutral
Price Target: n/a
Current: $1.39
Upside: -